Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. PRGS
8. VKTX
9. GS
10. UNG

Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
(NASDAQ: BNTX) Delayed: 100.87 +2.87 (2.93%)
Previous Close $98.00    52 Week High $ 
Open $98.00    52 Week Low $ 
Day High $102.23    P/E N/A 
Day Low $97.46    EPS $ 
Volume 1,050,808       

Pfizer Inc. (NYSE: PFE) Delayed: 27.93 +0.19 (0.68%)
Previous Close $27.74    52 Week High $37.39 
Open $27.74    52 Week Low $28.25 
Day High $28.00    P/E 16.93 
Day Low $27.49    EPS $1.65 
Volume 26,668,060